Tempest Therapeutics Inc (TPST)
3.18
-0.04
(-1.24%)
USD |
NASDAQ |
May 17, 16:00
3.20
+0.02
(+0.63%)
After-Hours: 07:34
Tempest Therapeutics Price to Book Value: 3.424 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 3.424 |
| May 16, 2024 | 3.467 |
| May 15, 2024 | 3.640 |
| May 14, 2024 | 3.661 |
| May 13, 2024 | 3.532 |
| May 10, 2024 | 3.500 |
| May 09, 2024 | 3.737 |
| May 08, 2024 | 3.737 |
| May 07, 2024 | 3.898 |
| May 06, 2024 | 4.017 |
| May 03, 2024 | 3.974 |
| May 02, 2024 | 3.812 |
| May 01, 2024 | 3.898 |
| April 30, 2024 | 3.737 |
| April 29, 2024 | 3.704 |
| April 26, 2024 | 3.812 |
| April 25, 2024 | 3.747 |
| April 24, 2024 | 3.704 |
| April 23, 2024 | 3.683 |
| April 22, 2024 | 3.489 |
| April 19, 2024 | 3.338 |
| April 18, 2024 | 3.414 |
| April 17, 2024 | 3.521 |
| April 16, 2024 | 3.607 |
| April 15, 2024 | 3.597 |
| Date | Value |
|---|---|
| April 12, 2024 | 3.866 |
| April 11, 2024 | 4.146 |
| April 10, 2024 | 4.006 |
| April 09, 2024 | 4.167 |
| April 08, 2024 | 4.297 |
| April 05, 2024 | 4.006 |
| April 04, 2024 | 4.846 |
| April 03, 2024 | 5.519 |
| April 02, 2024 | 5.481 |
| April 01, 2024 | 5.858 |
| March 28, 2024 | 3.242 |
| March 27, 2024 | 3.076 |
| March 26, 2024 | 3.076 |
| March 25, 2024 | 3.018 |
| March 22, 2024 | 3.018 |
| March 21, 2024 | 2.91 |
| March 20, 2024 | 3.117 |
| March 19, 2024 | 3.101 |
| March 18, 2024 | 3.208 |
| March 15, 2024 | 3.018 |
| March 14, 2024 | 2.844 |
| March 13, 2024 | 2.810 |
| March 12, 2024 | 2.784 |
| March 11, 2024 | 2.784 |
| March 08, 2024 | 2.792 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4343
Minimum
Mar 14 2022
5.858
Maximum
Apr 01 2024
1.606
Average
1.259
Median
May 20 2022
Price to Book Value Benchmarks
| CEL-SCI Corp | 4.808 |
| AIM ImmunoTech Inc | 2.107 |
| IGC Pharma Inc | 3.942 |
| NovaBay Pharmaceuticals Inc | -- |
| Protalix BioTherapeutics Inc | 2.806 |
Price to Book Value Related Metrics
| Price | 3.18 |
| Earnings Yield | -54.09% |
| Market Cap | 70.65M |